These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. The effect of U-50,488H, a kappa-opiate receptor agonist on tolerance to the analgesic and hyperthermic effects of morphine in the rat. Bhargava HN, Matwyshyn G, Ramarao P. Gen Pharmacol; 1991; 22(3):429-34. PubMed ID: 1651266 [Abstract] [Full Text] [Related]
26. Respiratory effects of receptor-selective opioids in rhesus monkeys. France CP, Woods JH. Prog Clin Biol Res; 1990; 328():295-8. PubMed ID: 2154784 [No Abstract] [Full Text] [Related]
27. Beneficial effects of the kappa opioid receptor agonist U-50488H in experimental acute brain and spinal cord injury. Hall ED, Wolf DL, Althaus JS, Von Voigtlander PF. Brain Res; 1987 Dec 01; 435(1-2):174-80. PubMed ID: 2827851 [Abstract] [Full Text] [Related]
28. Intracerebroventricular administration of kappa-agonists induces convulsions in mice. Bansinath M, Ramabadran K, Turndorf H, Shukla VK. Brain Res Bull; 1991 Jul 01; 27(1):75-9. PubMed ID: 1657321 [Abstract] [Full Text] [Related]
31. The selective kappa-opioid agonist, U-50,488H, produces antinociception in the rat via a supraspinal action. Czlonkowski A, Millan MJ, Herz A. Eur J Pharmacol; 1987 Oct 06; 142(1):183-4. PubMed ID: 2826175 [No Abstract] [Full Text] [Related]
37. Pharmacological activities of optically pure enantiomers of the kappa opioid agonist, U50,488, and its cis diastereomer: evidence for three kappa receptor subtypes. Rothman RB, France CP, Bykov V, De Costa BR, Jacobson AE, Woods JH, Rice KC. Eur J Pharmacol; 1989 Aug 29; 167(3):345-53. PubMed ID: 2553442 [Abstract] [Full Text] [Related]